These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 4797147)

  • 21. Structure-activity correlations between hydroxamic acids and their inhibitory powers on urease activity. I. A quantitative approach to the effect of hydrophobic character of acyl residue.
    Kumaki K; Tomioka S; Kobashi K; Hase J
    Chem Pharm Bull (Tokyo); 1972 Aug; 20(8):1599-606. PubMed ID: 4639301
    [No Abstract]   [Full Text] [Related]  

  • 22. Inhibition of urease activity by hydroxamic acid derivatives of amino acids.
    Kobashi K; Takebe S; Terashima N; Hase J
    J Biochem; 1975 Apr; 77(4):837-43. PubMed ID: 238968
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of urease activity but not growth of Helicobacter pylori by acetohydroxamic acid.
    Goldie J; Veldhuyzen van Zanten SJ; Jalali S; Richardson H; Hunt RH
    J Clin Pathol; 1991 Aug; 44(8):695-7. PubMed ID: 1890207
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [In vitro studies on the question of urea transformation in ruminal fluid. 2. Inhibitors and activators of ureolysis].
    Müller R; Kirchner I
    Z Tierphysiol Tierernahr Futtermittelkd; 1970 Nov; 27(1):35-44. PubMed ID: 5534886
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of Helicobacter pylori urease activity by hydroxamic acid derivatives.
    Odake S; Morikawa T; Tsuchiya M; Imamura L; Kobashi K
    Biol Pharm Bull; 1994 Oct; 17(10):1329-32. PubMed ID: 7874052
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Urease activity of Helicobacter pylori.
    Kobashi K
    J Clin Pathol; 1992 Apr; 45(4):367-8. PubMed ID: 1577984
    [No Abstract]   [Full Text] [Related]  

  • 27. Quantitative structure-activity relationships between hydroxamic acids and their urease inhibitory potency.
    Munakata K; Kobashi K; Hase J
    J Pharmacobiodyn; 1980 Sep; 3(9):457-62. PubMed ID: 7463305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Screening system for urease inhibitors using 13C-NMR.
    Chiyoda T; Iida K; Takatori K; Kajiwara M
    Chem Pharm Bull (Tokyo); 1998 Apr; 46(4):718-20. PubMed ID: 9579048
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hydrolysis of 14 C-biuret by in vitro rumen fermentation and crude biuretase preparations.
    Bauriedel WR
    J Anim Sci; 1971 Apr; 32(4):704-10. PubMed ID: 5571552
    [No Abstract]   [Full Text] [Related]  

  • 30. Synthesis, molecular docking and kinetic properties of β-hydroxy-β-phenylpropionyl-hydroxamic acids as Helicobacter pylori urease inhibitors.
    Xiao ZP; Peng ZY; Dong JJ; Deng RC; Wang XD; Ouyang H; Yang P; He J; Wang YF; Zhu M; Peng XC; Peng WX; Zhu HL
    Eur J Med Chem; 2013 Oct; 68():212-21. PubMed ID: 23974021
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution and changes in urease (EC 3.5.1.5) activity in Rumen Simulation Technique (Rusitec).
    Czerkawski JW; Breckenridge G
    Br J Nutr; 1982 Mar; 47(2):331-48. PubMed ID: 7039670
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Study on hydroxamic acids and their urease inhibitory potency by quantum chemistry calculation.
    Kanoda M; Shinoda H; Kobashi K; Hase J; Nagahara S
    J Pharmacobiodyn; 1983 Feb; 6(2):61-70. PubMed ID: 6864441
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CoMFA and CoMSIA 3D-QSAR analysis on hydroxamic acid derivatives as urease inhibitors.
    Ul-Haq Z; Wadood A; Uddin R
    J Enzyme Inhib Med Chem; 2009 Feb; 24(1):272-8. PubMed ID: 18608766
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Urease activity of adherent bacteria in the sheep rumen.
    Rybosová E; Javorský P; Havassy I; Horský K
    Physiol Bohemoslov; 1984; 33(5):411-6. PubMed ID: 6505073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the novel urease inhibitor N-(n-butyl) thiophosphoric triamide on ruminant nitrogen metabolism: I. In vitro urea kinetics and substrate digestion.
    Ludden PA; Harmon DL; Larson BT; Axe DE
    J Anim Sci; 2000 Jan; 78(1):181-7. PubMed ID: 10682820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S.E.M. study of urease-induced crystalluria in the presence of hydroxamic derivatives.
    Ben Amar M; L'Espérance G; Tawashi R
    Int Urol Nephrol; 1986; 18(3):227-33. PubMed ID: 3771124
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Urease activity of adherent bacteria and rumen fluid bacteria.
    Javorský P; Rybosová E; Havassy I; Horský K; Kmet V
    Physiol Bohemoslov; 1987; 36(1):75-81. PubMed ID: 2954172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acetohydroxamate, a urease inhibitor, inhibits the covalent binding reaction of complement proteins C3 and C4.
    Sim E; Jones A; Stanley L
    Acta Pharmacol Toxicol (Copenh); 1985 Oct; 57(4):304-6. PubMed ID: 4083040
    [No Abstract]   [Full Text] [Related]  

  • 39. Suppression of Helicobacter pylori-induced gastritis by urease inhibitors in Mongolian gerbils.
    Shibata H; Ohta T; Iimuro M; Kitamura T; Yokokura T; Wakabayashi K
    Gan To Kagaku Ryoho; 2002 Feb; 29 Suppl 1():154-8. PubMed ID: 11890100
    [No Abstract]   [Full Text] [Related]  

  • 40. Urease inhibitors for hepatic coma. II. Comparative efficacy of four lower hydroxamate homologs in vitro and in vivo.
    Fishbein WN; Daly JE
    Proc Soc Exp Biol Med; 1970 Sep; 134(4):1083-90. PubMed ID: 5457735
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.